ALDX Company Profile and Key Details

Q: Who are the executives of ALDX?

Mr. Kelly MizerVice President of Commercial Strategy & OperationsDr. Todd C. Brady M.D., Ph.D.Chief Executive Officer, Pres & DirectorDr. Stephen G. Machatha Ph.D.Chief Devel. OfficerMr. Bruce Greenberg CPA, M.B.A.Senior Vice President of Fin., Interim Chief Financial Officer & TreasurerDavid BurkeHead of Investor RelationsMr. Bruce Greenberg C.P.A., M.B.A.Senior Vice President of Fin., Interim Chief Financial Officer & Treasurer

NASDAQ : ALDX

Aldeyra Therapeutics

$5.53

0.44+8.64%

At Close 4:00 PM

59.45

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Aldeyra Therapeutics, Inc. (ALDX) stock surged +8.64%, trading at $5.53 on NASDAQ, up from the previous close of $5.09. The stock opened at $5.21, fluctuating between $5.15 and $5.61 in the recent session.

Stock Snapshot

5.09

Prev. Close

332.7M

Market Cap

5.15

Day Low

-7.58

P/E Ratio

-0.73

EPS (TTM)

-0.51

Cash Flow per Share

5.21

Open

60.16M

Number of Shares

5.61

Day High

96.88%

Free Float in %

2.02

Book Value

961.98K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 06, 2026	5.21	5.61	5.15	5.53	973.38K
Feb 05, 2026	5.19	5.44	5.08	5.09	600.77K
Feb 04, 2026	5.45	5.48	4.92	5.22	935.66K
Feb 03, 2026	5.45	5.60	5.31	5.41	556.41K
Feb 02, 2026	5.32	5.59	5.25	5.43	355.68K
Jan 30, 2026	5.45	5.93	5.27	5.36	742.81K
Jan 29, 2026	5.42	5.44	5.23	5.32	525.36K
Jan 28, 2026	5.55	5.55	5.37	5.42	595.66K
Jan 27, 2026	5.25	5.65	5.25	5.54	864.03K
Jan 26, 2026	5.16	5.31	5.05	5.23	620.22K
Jan 23, 2026	5.21	5.43	5.09	5.19	1.26M
Jan 22, 2026	5.01	5.39	4.97	5.22	942.24K
Jan 21, 2026	4.74	5.13	4.74	4.99	1.19M
Jan 20, 2026	4.52	4.83	4.39	4.75	1.02M
Jan 16, 2026	4.39	4.74	4.22	4.63	1.63M
Jan 15, 2026	4.28	4.45	4.20	4.41	835.17K
Jan 14, 2026	4.14	4.30	4.08	4.24	593.67K
Jan 13, 2026	4.15	4.16	3.96	4.14	527.26K
Jan 12, 2026	4.07	4.19	3.95	4.13	616.92K
Jan 09, 2026	4.24	4.33	4.01	4.11	643.44K

Contact Details

Lexington, MA 02421

United States

https://www.aldeyra.com 781 761 4904

About Company

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of retinitis pigmentosa, as well as for treating primary vitreoretinal lymphoma. The company has a license agreement with Madrigal Pharmaceuticals, Inc. for developing ADX-1612, which inhibits the protein chaperome for the treatment of inflammatory diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

Stock Peers

ARGX

-8.86-1.08%

argenx SE$811.45 REGN

18.88+2.46%

Regeneron Pharmaceuticals, Inc.$785.51 UTHR

6.43+1.34%

United Therapeutics Corporation$485.36 VRTX

19.11+4.17%

Vertex Pharmaceuticals Incorporated$477.92 MDGL

14.18+3.06%

Madrigal Pharmaceuticals, Inc.$477.60 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

-3.08-0.93%

Alnylam Pharmaceuticals, Inc.$328.16 PRAX

13.95+4.56%

Praxis Precision Medicines, Inc.$319.57 KRYS

5.1+1.91%

Krystal Biotech, Inc.$272.74 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Aldeyra Therapeutics, Inc. (ALDX) stock price?

Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) stock price is $5.53 in the last trading session. During the trading session, ALDX stock reached the peak price of $5.61 while $5.15 was the lowest point it dropped to. The percentage change in ALDX stock occurred in the recent session was 8.64% while the dollar amount for the price change in ALDX stock was $0.44.

ALDX's industry and sector of operation?

The NASDAQ listed ALDX is part of Biotechnology industry that operates in the broader Healthcare sector. Aldeyra Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ALDX?

Mr. Kelly Mizer
Vice President of Commercial Strategy & Operations
Dr. Todd C. Brady M.D., Ph.D.
Chief Executive Officer, Pres & Director
Dr. Stephen G. Machatha Ph.D.
Chief Devel. Officer
Mr. Bruce Greenberg CPA, M.B.A.
Senior Vice President of Fin., Interim Chief Financial Officer & Treasurer
David Burke
Head of Investor Relations
Mr. Bruce Greenberg C.P.A., M.B.A.
Senior Vice President of Fin., Interim Chief Financial Officer & Treasurer

How ALDX did perform over past 52-week?

ALDX's closing price is 385.09% higher than its 52-week low of $1.14 where as its distance from 52-week high of $7.20 is -23.19%.

How many employees does ALDX have?

Number of ALDX employees currently stands at 9.

Link for ALDX official website?

Official Website of ALDX is: https://www.aldeyra.com

How do I contact ALDX?

ALDX could be contacted at phone 781 761 4904 and can also be accessed through its website. ALDX operates from 131 Hartwell Avenue, Lexington, MA 02421, United States.

How many shares of ALDX are traded daily?

ALDX stock volume for the day was 961.98K shares. The average number of ALDX shares traded daily for last 3 months was 1.06M.

What is the market cap of ALDX currently?

The market value of ALDX currently stands at $332.70M with its latest stock price at $5.53 and 60.16M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	9
Beta	0.85
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	9
Beta	0.85
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

ALDX Company Profile and Key Details

Aldeyra Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Key Takeaways

Price Forecast & Outlook

Valuation Metrics